Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cellular Senescence Triggered by Food and Environmental Genotoxins.

International journal of molecular sciences·2026
Same author

Senotherapeutics in Malignant Brain Cancer Therapy.

Current oncology reports·2025
Same author

IDH1 Mutation Impacts DNA Repair Through ALKBH2 Rendering Glioblastoma Cells Sensitive to Artesunate.

Biomedicines·2025
Same author

Therapy-induced senescence of glioblastoma cells is determined by the p21<sup>CIP1</sup>-CDK1/2 axis and does not require activation of DREAM.

Cell death & disease·2025
Same author

Apoptotic and senolytic effects of hERG/Eag1 channel blockers in combination with temozolomide in human glioblastoma cells.

Naunyn-Schmiedeberg's archives of pharmacology·2025
Same author

Oligoclonal bands and kappa free light chains: Competing parameters or complementary biomarkers?

Autoimmunity reviews·2025

Related Experiment Video

Updated: Sep 5, 2025

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells
05:29

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

Published on: March 28, 2021

2.9K

Temozolomide - Just a Radiosensitizer?

Bernd Kaina1, Lea Beltzig1, Herwig Strik2

  • 1Institute of Toxicology, University Medical Center, Mainz, Germany.

Frontiers in Oncology
|July 5, 2022
PubMed
Summary

Temozolomide (TMZ) and radiation therapy are standard glioblastoma treatments. This study explores their combined effects, suggesting optimal timing for TMZ and radiation may enhance glioblastoma treatment outcomes.

Keywords:
DNA repairMGMTapoptosisglioblastomaradiotherapytemozolomidetreatment protocols

More Related Videos

Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens
09:26

Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens

Published on: July 29, 2011

16.8K
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

21.5K

Related Experiment Videos

Last Updated: Sep 5, 2025

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells
05:29

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

Published on: March 28, 2021

2.9K
Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens
09:26

Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens

Published on: July 29, 2011

16.8K
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

21.5K

Area of Science:

  • Oncology
  • Radiation Oncology
  • Molecular Biology

Background:

  • Temozolomide (TMZ) and radiation therapy are the standard treatment for glioblastoma.
  • TMZ is considered a radiation sensitizer in this adjuvant setting.
  • Both TMZ and radiation induce DNA damage, triggering apoptosis, senescence, and autophagy, suggesting independent actions.

Purpose of the Study:

  • To investigate the interaction between TMZ and radiation in glioblastoma treatment.
  • To explore the molecular mechanisms underlying the combined effects of TMZ and radiation.
  • To propose optimal timing for radio-chemotherapy based on DNA lesion repair and interactions.

Main Methods:

  • Review of existing literature on TMZ and radiation therapy in glioblastoma.
  • Analysis of molecular mechanisms of DNA damage and repair induced by TMZ and radiation.
  • Discussion of experimental data, including cell culture results, on combined treatment effects.

Main Results:

  • Cell culture experiments show heterogeneous results regarding the combined effects of TMZ and radiation.
  • Some data suggest enhanced cytotoxic effects when TMZ is administered before radiation.
  • The molecular mechanisms of TMZ and radiation suggest potential for additive or synergistic interactions.

Conclusions:

  • The optimal timing of TMZ and radiation therapy may be crucial for maximizing treatment efficacy in glioblastoma.
  • Understanding the interplay of DNA lesions, repair pathways, and cellular responses is key.
  • Further research is needed to elucidate the precise mechanisms and optimize treatment protocols.